[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Kidney;
DOI=10.1016/S0092-8674(00)80209-3; PubMed=9108485 [NCBI, ExPASy, EBI, Israel, Japan]
Simonet W.S.,
Lacey D.L.,
Dunstan C.R.,
Kelley M.,
Chang M.-S.,
Luethy R.,
Nguyen H.Q.,
Wooden S.,
Bennett L.,
Boone T.,
Shimamoto G.,
Derose M.,
Elliott R.,
Colombero A.,
Tan H.-L.,
Trail G.,
Sullivan J.,
Davy E.,
Bucay N., ![]()
Renshaw-Gegg L.,
Hughes T.M.,
Hill D.,
Pattison W.,
Campbell P.,
Sander S.,
Van G.,
Tarpley J.,
Derby P.,
Lee R.,
Suggs S.,
Boyle W.J.;
"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.";
Cell 89:309-319(1997).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Lung cancer;
DOI=10.1210/en.139.3.1329; PubMed=9492069 [NCBI, ExPASy, EBI, Israel, Japan]
Yasuda H.,
Shima N.,
Nakagawa N.,
Mochizuki S.,
Yano K.,
Fujise N.,
Sato Y.,
Goto M.,
Yamaguchi K.,
Kuriyama M.,
Kanno T.,
Murakami A.,
Tsuda E.,
Morinaga T.,
Higashio K.;
"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.";
Endocrinology 139:1329-1337(1998).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASN-3.
TISSUE=Placenta;
DOI=10.1046/j.1432-1327.1998.2540685.x; PubMed=9688283 [NCBI, ExPASy, EBI, Israel, Japan]
Morinaga T.,
Nakagawa N.,
Yasuda H.,
Tsuda E.,
Higashio K.;
"Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor.";
Eur. J. Biochem. 254:685-691(1998).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Kidney;
DOI=10.1038/ng1285; PubMed=14702039 [NCBI, ExPASy, EBI, Israel, Japan]
Ota T.,
Suzuki Y.,
Nishikawa T.,
Otsuki T.,
Sugiyama T.,
Irie R.,
Wakamatsu A.,
Hayashi K.,
Sato H.,
Nagai K.,
Kimura K.,
Makita H.,
Sekine M.,
Obayashi M.,
Nishi T.,
Shibahara T.,
Tanaka T.,
Ishii S.,
Yamamoto J., ![]()
Saito K.,
Kawai Y.,
Isono Y.,
Nakamura Y.,
Nagahari K.,
Murakami K.,
Yasuda T.,
Iwayanagi T.,
Wagatsuma M.,
Shiratori A.,
Sudo H.,
Hosoiri T.,
Kaku Y.,
Kodaira H.,
Kondo H.,
Sugawara M.,
Takahashi M.,
Kanda K.,
Yokoi T.,
Furuya T.,
Kikkawa E.,
Omura Y.,
Abe K.,
Kamihara K.,
Katsuta N.,
Sato K.,
Tanikawa M.,
Yamazaki M.,
Ninomiya K.,
Ishibashi T.,
Yamashita H.,
Murakawa K.,
Fujimori K.,
Tanai H.,
Kimata M.,
Watanabe M.,
Hiraoka S.,
Chiba Y.,
Ishida S.,
Ono Y.,
Takiguchi S.,
Watanabe S.,
Yosida M.,
Hotuta T.,
Kusano J.,
Kanehori K.,
Takahashi-Fujii A.,
Hara H.,
Tanase T.-O.,
Nomura Y.,
Togiya S.,
Komai F.,
Hara R.,
Takeuchi K.,
Arita M.,
Imose N.,
Musashino K.,
Yuuki H.,
Oshima A.,
Sasaki N.,
Aotsuka S.,
Yoshikawa Y.,
Matsunawa H.,
Ichihara T.,
Shiohata N.,
Sano S.,
Moriya S.,
Momiyama H.,
Satoh N.,
Takami S.,
Terashima Y.,
Suzuki O.,
Nakagawa S.,
Senoh A.,
Mizoguchi H.,
Goto Y.,
Shimizu F.,
Wakebe H.,
Hishigaki H.,
Watanabe T.,
Sugiyama A.,
Takemoto M.,
Kawakami B.,
Yamazaki M.,
Watanabe K.,
Kumagai A.,
Itakura S.,
Fukuzumi Y.,
Fujimori Y.,
Komiyama M.,
Tashiro H.,
Tanigami A.,
Fujiwara T.,
Ono T.,
Yamada K.,
Fujii Y.,
Ozaki K.,
Hirao M.,
Ohmori Y.,
Kawabata A.,
Hikiji T.,
Kobatake N.,
Inagaki H.,
Ikema Y.,
Okamoto S.,
Okitani R.,
Kawakami T.,
Noguchi S.,
Itoh T.,
Shigeta K.,
Senba T.,
Matsumura K.,
Nakajima Y.,
Mizuno T.,
Morinaga M.,
Sasaki M.,
Togashi T.,
Oyama M.,
Hata H.,
Watanabe M.,
Komatsu T.,
Mizushima-Sugano J.,
Satoh T.,
Shirai Y.,
Takahashi Y.,
Nakagawa K.,
Okumura K.,
Nagase T.,
Nomura N.,
Kikuchi H.,
Masuho Y.,
Yamashita R.,
Nakai K.,
Yada T.,
Nakamura Y.,
Ohara O.,
Isogai T.,
Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human cDNAs.";
Nat. Genet. 36:40-45(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-3.
TISSUE=Lung;
Suzuki Y.,
Sugano S.,
Totoki Y.,
Toyoda A.,
Takeda T.,
Sakaki Y.,
Tanaka A.,
Yokoyama S.;
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASN-3 AND MET-104.
NIEHS SNPs program;
Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
|
[7]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASN-3.
TISSUE=Eye;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[8]
|
PROTEIN SEQUENCE OF 22-36 AND 378-401.
DOI=10.1006/bbrc.1998.8443; PubMed=9571159 [NCBI, ExPASy, EBI, Israel, Japan]
Tomoyasu A.,
Goto M.,
Fujise N.,
Mochizuki S.,
Yasuda H.,
Morinaga T.,
Tsuda E.,
Higashio K.;
"Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor.";
Biochem. Biophys. Res. Commun. 245:382-387(1998).
|
[9]
|
PROTEIN SEQUENCE OF 22-36.
DOI=10.1110/ps.04682504; PubMed=15340161 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang Z.,
Henzel W.J.;
"Signal peptide prediction based on analysis of experimentally verified cleavage sites.";
Protein Sci. 13:2819-2824(2004).
|
[10]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 22-393.
TISSUE=Placenta;
PubMed=12110935 [NCBI, ExPASy, EBI, Israel, Japan]
He Z.-Y.,
Yang G.-Z.,
Zhang W.-J.,
Wu X.-F.;
"Cloning and expression of osteoprotegerin from Homo sapiens.";
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 31:680-684(1999).
|
[11]
|
PROTEIN SEQUENCE OF 242-255; 354-359 AND 369-378, AND FUNCTION.
DOI=10.1006/bbrc.1997.6603; PubMed=9168977 [NCBI, ExPASy, EBI, Israel, Japan]
Tsuda E.,
Goto M.,
Mochizuki S.,
Yano K.,
Kobayashi F.,
Morinaga T.,
Higashio K.;
"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.";
Biochem. Biophys. Res. Commun. 234:137-142(1997).
|
[12]
|
INTERACTION WITH TRAIL.
DOI=10.1074/jbc.273.23.14363; PubMed=9603945 [NCBI, ExPASy, EBI, Israel, Japan]
Emery J.G.,
McDonnell P.,
Burke M.B.,
Deen K.C.,
Lyn S.,
Silverman C.,
Dul E.,
Appelbaum E.R.,
Eichman C.,
DiPrinzio R.,
Dodds R.A.,
James I.E.,
Rosenberg M.,
Lee J.C.,
Young P.R.;
"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.";
J. Biol. Chem. 273:14363-14367(1998).
|
[13]
|
CHARACTERIZATION, AND MUTAGENESIS OF CYS-400.
DOI=10.1074/jbc.273.9.5117; PubMed=9478964 [NCBI, ExPASy, EBI, Israel, Japan]
Yamaguchi K.,
Kinosaki M.,
Goto M.,
Kobayashi F.,
Tsuda E.,
Morinaga T.,
Higashio K.;
"Characterization of structural domains of human osteoclastogenesis inhibitory factor.";
J. Biol. Chem. 273:5117-5123(1998).
|
[14]
|
REVIEW.
DOI=10.1002/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO;2-D; PubMed=11505389 [NCBI, ExPASy, EBI, Israel, Japan]
Hofbauer L.C.,
Neubauer A.,
Heufelder A.E.;
"Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases.";
Cancer 92:460-470(2001).
|
[15]
|
VARIANT JPD ASP-182 DEL.
DOI=10.1093/hmg/11.18.2119; PubMed=12189164 [NCBI, ExPASy, EBI, Israel, Japan]
Cundy T.,
Hegde M.,
Naot D.,
Chong B.,
King A.,
Wallace R.,
Mulley J.,
Love D.R.,
Seidel J.,
Fawkner M.,
Banovic T.,
Callon K.E.,
Grey A.B.,
Reid I.R.,
Middleton-Hardie C.A.,
Cornish J.;
"A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.";
Hum. Mol. Genet. 11:2119-2127(2002).
|
|
ExPASy Home page
SIB Switzerland
